BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37894903)

  • 1. Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases.
    Tian Y; Zhang M; Heng P; Hou H; Wang B
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy.
    Khan S; Bjij I; Betz RM; Soliman ME
    Future Med Chem; 2018 May; 10(9):1003-1015. PubMed ID: 29629569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computation of relative binding free energy for an inhibitor and its analogs binding with Erk kinase using thermodynamic integration MD simulation.
    Wu KW; Chen PC; Wang J; Sun YC
    J Comput Aided Mol Des; 2012 Oct; 26(10):1159-69. PubMed ID: 22986633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a cysteine residue in the active site of ERK and the MAPKK family.
    Ohori M; Kinoshita T; Yoshimura S; Warizaya M; Nakajima H; Miyake H
    Biochem Biophys Res Commun; 2007 Feb; 353(3):633-7. PubMed ID: 17194451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent vs. Non-Covalent Inhibition: Tackling Drug Resistance in EGFR - A Thorough Dynamic Perspective.
    Akher FB; Farrokhzadeh A; Soliman MES
    Chem Biodivers; 2019 Mar; 16(3):e1800518. PubMed ID: 30548188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of covalent binding of ibrutinib to Bruton's tyrosine kinase revealed by QM/MM calculations.
    Voice AT; Tresadern G; Twidale RM; van Vlijmen H; Mulholland AJ
    Chem Sci; 2021 Jan; 12(15):5511-5516. PubMed ID: 33995994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Awoonor-Williams E; Abu-Saleh AAA
    Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.
    Tanneeru K; Guruprasad L
    PLoS One; 2013; 8(11):e78556. PubMed ID: 24236021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using thermodynamic integration MD simulation to compute relative protein-ligand binding free energy of a GSK3β kinase inhibitor and its analogs.
    Lee HC; Hsu WC; Liu AL; Hsu CJ; Sun YC
    J Mol Graph Model; 2014 Jun; 51():37-49. PubMed ID: 24858254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase: mechanisms of covalent inhibition of wild-type and H447I mutant determined by computational analyses.
    Cheng Y; Cheng X; Radić Z; McCammon JA
    J Am Chem Soc; 2007 May; 129(20):6562-70. PubMed ID: 17461584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells.
    Yu Y; Nie Y; Feng Q; Qu J; Wang R; Bian L; Xia J
    Mol Pharm; 2017 May; 14(5):1548-1557. PubMed ID: 28060514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomistic understanding of the C·T mismatched DNA base pair tautomerization via the DPT: QM and QTAIM computational approaches.
    Brovarets' OO; Hovorun DM
    J Comput Chem; 2013 Nov; 34(30):2577-90. PubMed ID: 23955922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the Impact of Covalent and Non-covalent Binding Modes of Inhibitors on Bruton's Tyrosine Kinase in the Treatment of B Cell Malignancies - Computational Insights.
    Issahaku AR; Soliman MES
    Curr Pharm Biotechnol; 2023; 24(6):814-824. PubMed ID: 35718983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
    Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
    Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. o-Quinone methide as alkylating agent of nitrogen, oxygen, and sulfur nucleophiles. The role of H-bonding and solvent effects on the reactivity through a DFT computational study.
    Di Valentin C; Freccero M; Zanaletti R; Sarzi-Amadè M
    J Am Chem Soc; 2001 Aug; 123(34):8366-77. PubMed ID: 11516286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches.
    Miyamoto S; Kollman PA
    Proteins; 1993 Jul; 16(3):226-45. PubMed ID: 8346190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of hydrogen bonding interactions on the C-H bond activation step in class I ribonucleotide reductases.
    Zipse H
    Org Biomol Chem; 2003 Feb; 1(4):692-9. PubMed ID: 12929456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear Discriminant Analysis for the in Silico Discovery of Mechanism-Based Reversible Covalent Inhibitors of a Serine Protease: Application of Hydration Thermodynamics Analysis and Semi-empirical Molecular Orbital Calculation.
    Masuda Y; Yoshida T; Yamaotsu N; Hirono S
    Chem Pharm Bull (Tokyo); 2018; 66(4):399-409. PubMed ID: 29607905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).
    Wei D; Tang M; Zhan CG
    Org Biomol Chem; 2015 Jun; 13(24):6857-65. PubMed ID: 26018983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease.
    Hognon C; Marazzi M; García-Iriepa C
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.